Atlas Trials

Feasibility of Chemotherapy De-escalation in Early-Stage HER2 Positive Breast Cancer

Clinical trial NCT04419181 · WITHDRAWN

Trial details

NCT number
NCT04419181
Sponsor
University of Rochester
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
HER2-positive Breast Cancer
Start date
2025-08-11
Primary completion
2026-06-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.